Over the fourth quarter of 2024, Carmignac Absolute Return Europe (A EUR Acc share class) realized a positive performance of +0.64%.
The fourth quarter was challenging for investors, marked by a volatile performance in European equity markets driven by macroeconomic and geopolitical factors. Initially, the quarter began steadily, but political uncertainty and rising bond yields in developed markets triggered a sharp rotation and selloff in October, resulting in a 3% decline in European equities for the month. This was followed by a rally in the US equity market, fuelled by optimism over Trump's election victory and anticipated tax cuts, deregulation, and other stimulatory measures. However, Europe lagged behind the US due to concerns over the potential negative impact of Trump's trade policies and tariffs on the European economy.
In December, the early rally in the US market reversed due to profit-taking, higher bond yields, and a shift in the Federal Reserve's (FED) messaging. Despite lower short-term interest rates in developed markets during Q4, the rise in US 10-year Treasury yields from 3.78% to 4.57% caused rotational volatility and negatively affected equity markets.
Overall, European equities declined by 2.9% for the quarter. Only the Travel & Leisure, Financials, Media, and Insurance sectors posted positive returns, while all other sectors were in the red. The worst-performing sectors were Real Estate, Chemicals, Basic Materials, and Healthcare.
Against that backdrop, we are pleased to be able to report a positive return for the quarter due to a combination of positive long /short stock picking and disciplined risk management. Against a backdrop of volatility and general uncertainty we maintained a relatively low gross of either side of 100% for the quarter and a beta adjusted net dynamically flexed between 10% and 30%.
Our biggest positive contributions came from Financials, Consumer Discretionary, Healthcare and Communications on the long side. Our short book made a positive return across the board with the largest contributions coming from Consumer stocks, Materials, Healthcare and Technology stock shorts. In addition positive contributions came from our futures and put option hedges, which helped to offset some lagging long positions in the Technology, Industrials, Real Estate and Utilities sectors.
As always, we endeavoured to take advantage of market gyrations to take profits and add shorts where required on strength and to buy mispriced assets on weakness. In terms of portfolio adjustments, the key sectoral moves were to temporarily reduce Technology, Utilities and Staples exposure over the quarter and add to Financials, long duration Industrials and Healthcare, particularly after the selloff. The short book required diligent management to lock in profits on dips and as shares fell to hit our price targets. As always, we tend to trade our short book more frequently as stocks fall in anticipation to then reestablish those positions once again as markets rally.
Long Galderma – positive earnings and positive announcements on product pipeline | Long DSM – high multiple stock being held back due to rising bond yields |
Long Deutsche Telekom – earnings delivery and strong performance for their US business | Long EON – failed to obtain recalculation of regulatory costs for network capex |
Long Pandora – earnings beat and raised guidance | Long Cellnex – negative impact of rising bond yields |
Long SAP – earnings beat and management guiding for accelerating growth | Long Zealand – disappointing drug trial data for peer Novo Nordisk took the peer group down sharply |
Long Lululemon – better than expected earnings | Long Merlin Properties – real estate impacted by higher yields |
As we enter 2025, numerous unpredictable variables loom, including the impact of Trump's presidency and the uncertainty surrounding inflation and rate cuts. Central bank actions will be data-dependent, reminding us of the inaccurate market predictions at the start of 2024.
We believe this will be a year to remain committed to long-term investment themes while also being agile and tactical. We aim to maintain a balanced outlook and investment horizon, anticipating that European equities will continue to present significant opportunities for both our long and short positions.
In Q1, we plan to capitalize on the year-end volatility, when mean reversion often leads to recoveries in last year’s losing sectors or stocks, while previous winners underperform. These temporary shifts create opportunities for both our long and short positions. However, our stock selection will primarily hinge on corporate earnings outlook, with immediate focus on FY24 results and forward guidance.
While the fund possesses significant geographic flexibility, which we aim to leverage when optimal opportunities arise, our primary focus will remain on Europe. As we continue to argue, this is a great ‘hunting’ ground for our opportunistic and style agnostic, long/short strategy.
As we approach 2025, we see significant potential for our Long book to diversify beyond our usual global structural winners. Sentiment towards European equities is currently at a low point, with positioning remaining minimal following another year of EU equity outflows. This scenario presents a compelling opportunity, particularly if conditions start to improve. Historically, global investors tend to focus on Europe when valuations are exceptionally low or when there is a shift in the narrative. We believe now is an opportune moment to capitalize on this potential shift.
Potential catalyst for a more positive European outlook into 2025;
In summary, we see several potential positive catalysts for EU value and cyclicality, which could quickly improve the outlook for European equities, especially given the current low investor exposure. We are selectively adding risk, both tactically and on structural themes that we believe will benefit in the coming months.
We maintain our barbell approach with structural Longs in Electrification, Healthcare, EU Banks, Communication, and Technology. Our short book remains focused on late-cycle Industrials, Transport, and selective Consumer Discretionary names. Additionally, we are now incorporating shorter cyclical, deep value names that we expect to benefit from the anticipated positive shifts.
*Risk Scale from the KID (Key Information Document). Risk 1 does not mean a risk-free investment. This indicator may change over time. **The Sustainable Finance Disclosure Regulation (SFDR) 2019/2088 is a European regulation that requires asset managers to classify their funds as either 'Article 8' funds, which promote environmental and social characteristics, 'Article 9' funds, which make sustainable investments with measurable objectives, or 'Article 6' funds, which do not necessarily have a sustainability objective. For more information please refer to https://eur-lex.europa.eu/eli/reg/2019/2088/oj.
Carmignac Absolute Return Europe | -8.0 | 8.9 | 14.6 | 4.4 | -1.3 | 5.2 | 12.6 | -6.4 | 0.0 | 3.6 |
Carmignac Absolute Return Europe | - 0.0 % | + 2.8 % | + 3.4 % |
Source: Carmignac at 31 Jan 2025.
Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor).
Reference Indicator: -
Marketing communication. Please refer to the KID/KIID, prospectus of the fund before making any final investment decisions. This document is intended for professional clients.
This material may not be reproduced, in whole or in part, without prior authorisation from the Management Company. This material does not constitute a subscription offer, nor does it constitute investment advice. This material is not intended to provide, and should not be relied on for, accounting, legal or tax advice. This material has been provided to you for informational purposes only and may not be relied upon by you in evaluating the merits of investing in any securities or interests referred to herein or for any other purposes. The information contained in this material may be partial information and may be modified without prior notice. They are expressed as of the date of writing and are derived from proprietary and non-proprietary sources deemed by Carmignac to be reliable, are not necessarily all-inclusive and are not guaranteed as to accuracy. As such, no warranty of accuracy or reliability is given and no responsibility arising in any other way for errors and omissions (including responsibility to any person by reason of negligence) is accepted by Carmignac, its officers, employees or agents.
Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice. The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
Morningstar Rating™ : © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
Access to the Funds may be subject to restrictions regarding certain persons or countries. This material is not directed to any person in any jurisdiction where (by reason of that person’s nationality, residence or otherwise) the material or availability of this material is prohibited. Persons in respect of whom such prohibitions apply must not access this material. Taxation depends on the situation of the individual. The Funds are not registered for retail distribution in Asia, in Japan, in North America, nor are they registered in South America. Carmignac Funds are registered in Singapore as restricted foreign scheme (for professional clients only). The Funds have not been registered under the US Securities Act of 1933. The Funds may not be offered or sold, directly or indirectly, for the benefit or on behalf of a «U.S. person», according to the definition of the US Regulation S and FATCA.
The risks, fees and ongoing charges are described in the KID (Key Information Document). The KID must be made available to the subscriber prior to subscription. The subscriber must read the KID. Investors may lose some or all their capital, as the capital in the funds are not guaranteed. The Funds present a risk of loss of capital.
The Funds’ prospectus, KIDs, NAVs and annual reports are available at www.carmignac.com, or upon request to the Management Carmignac Portfolio refers to the sub-funds of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive. The French investment funds (fonds communs de placement or FCP) are common funds in contractual form conforming to the UCITS or AIFM Directive under French law.
In France, Luxembourg, Sweden: The risks, fees and ongoing charges are described in the KID (Key Information Document). The KID must be made available to the subscriber prior to subscription. The subscriber must read the KID. Investors may lose some or all their capital, as the capital in the funds are not guaranteed. The Funds present a risk of loss of capital. The Funds’ prospectus, KIDs, NAV and annual reports are available at www.carmignac.com, or upon request to the Management.
In the United Kingdom: the Funds’ respective prospectuses, KIIDs and annual reports are available at www.carmignac.co.uk, or upon request to the Management Company, or for the French Funds, at the offices of the Facilities Agent at BNP PARIBAS SECURITIES SERVICES, operating through its branch in London: 55 Moorgate, London EC2R. This document was prepared by Carmignac Gestion, Carmignac Gestion Luxembourg or Carmignac UK Ltd. FP Carmignac ICVC (the “Company”) is an Investment Company with variable capital incorporated in England and Wales under registered number 839620 and is authorised by the FCA with effect from 4 April 2019 and launched on 15 May 2019. FundRock Partners Limited is the Authorised Corporate Director (the “ACD”) of the Company and is authorised and regulated by the FCA. Registered Office: Hamilton Centre, Rodney Way, Chelmsford, Essex, CM1 3BY, UK; Registered in England and Wales with number 4162989. Carmignac Gestion Luxembourg SA has been appointed as the Investment Manager and distributor in respect of the Company. Carmignac UK Ltd (Registered in England and Wales with number 14162894) has been appointed as a sub-Investment Manager of the Company and is authorised and regulated by the Financial Conduct Authority with FRN:984288.
In Switzerland: the prospectus, KIDs and annual report are available at www.carmignac.ch, or through our representative in Switzerland, CACEIS (Switzerland), S.A., Route de Signy 35, CH-1260 Nyon. The paying agent is CACEIS Bank, Montrouge, Nyon Branch / Switzerland, Route de Signy 35, 1260 Nyon.
The Management Company can cease promotion in your country anytime.
Investors have access to a summary of their rights in English on the following links: UK ; Switzerland ; France ; Luxembourg ; Sweden.